Path Corporation (TYO:3840)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Ai and Technology Business	50.15M	5.84M	-	-	-
Beauty & Wellness Business	855.97M	1.04B	-	-	-
Regenerative Medicine Related Business ( Excluding Sustainable Business)	488.54M	364.02M	409.43M	-	-
Investment Business	40.00M	12.15M	-	-	-
Cosmetics Business	949.02M	798.71M	-	-	-
Unallocated Adjustment	-23.36M	-	-12.00K	-4.72M	-
Sustainable Business	7.94M	22.14M	42.21M	-	-
Market Expansion Business	1.99M	7.60M	-	-	-
Cosmetics, Beauty and Wellness Business	-	-	1.87B	1.94B	2.11B
Sustainable and Regenerative Medicine Business	-	-	-	57.35M	450.00K
Total	2.37B	2.25B	2.32B	1.99B	2.11B

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Japan	2.37B	2.25B	2.32B	1.99B	2.11B
Total	2.37B	2.25B	2.32B	1.99B	2.11B

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error